Are you Sang-Yong Kim?

Claim your profile

Publications (1)2.65 Total impact

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this study, 22 new betulinic acid (BA) derivatives were synthesized and tested for their inhibition of the chymotrypsin-like activity of 20S proteasome. From the SAR study, we concluded that the C-3 and C-30 positions are the pharmacophores for increasing the proteasome inhibition effects, and larger lipophilic or aromatic side chains are favored at these positions. Among the BA derivatives tested, compounds 13, 20, and 21 showed the best proteasome inhibition activity with IC(50) values of 1.42, 1.56, and 1.80 μM, respectively, which are three to fourfold more potent than the proteasome inhibition controls LLM-F and lactacystin.
    Bioorganic & medicinal chemistry letters 07/2011; 21(19):5944-7. · 2.65 Impact Factor